J&J Unit Asks 3rd Circ. To Nix Cert. In Blood Test Antitrust Row
A Johnson & Johnson unit told the Third Circuit on Monday that buyers of reagents used in blood tests did not meet the burden to secure class status in multidistrict litigation...To view the full article, register now.
Already a subscriber? Click here to view full article